Title |
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants |
|---|---|
Involved |
Rüdiger Hehlmann (Verfasser) |
Published |
Freiburg: Universität |
Extent |
Online-Ressource |
Language |
|
Country |
|
Topic |
|
DDC notation |
|
Persistent identifier |
urn:nbn:de:bsz:25-freidok-1935301 (URN) |
Further information |
Leukemia. - 31 (2017) , 2398-2406, ISSN: 1476-5551 |
Record ID |
1228270155 |
Please note
The beta version does not yet contain all functions and information of the DNB portal catalogue. If you are missing information or want to order a medium, please visit the page in the DNB portal catalogue via the following link: